Clinical Trial Update: Study to Assess the Safety and Effects of Autologous Adipose-Derived Stromal Cells in Patients With Alzheimer's Disease [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating the safety and effects of autologous adipose-derived stromal cells in Alzheimer's disease has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Autologous adipose-derived stromal cells (adipose-derived stromal cells)

Snippet

Sponsor: Ageless Regenerative Institute | Conditions: Alzheimer's Disease | Phase 1, Phase 2 | Status: WITHDRAWN